Cadila Pharmaceuticals (Ethiopia) Plc (CPEL), the joint venture between Cadila Pharmaceuticals Ltd, Ahmedabad, and Almeta Impex Plc, Ethiopia, has bagged the current Good Manufacturing Practices (cGMP) certificate and has become the first pharmaceutical formulation manufacturing company in the African nation to comply with cGMP, laid down by World Health Organisation (WHO).
The Minister of Industry of The Federal Democratic Republic of Ethiopia, Mr. Ato Mekonnen Manyazewak, presented the cGMP certificate to CPEL at a ceremony on Saturday last, according to a Cadila Pharma press release here on Monday.
Key ministers of the Government of Ethiopia, ambassadors, and the management of Cadila Pharmaceuticals Ltd were present on the occasion. Commissioned in 2007 and spread over 10,600 square metres of land, CPEL is a leading pharmaceutical manufacturing plant in Ethiopia. It has the capacity to manufacture 390 million tablets, 165 million capsules and 1.44 million litres of liquid per annum.